BioAtla (BCAB) Competitor Comparison
We are evaluating the key criteria listed to compare BioAtla (BCAB) against its competitors in the Biotechnology industry.
Market Capitalization
244 / 368Gross Profits
223 / 278Total Revenue
0 / 300EBITDA
232 / 337Free Cashflow
228 / 352Quick Ratio
219 / 357Earnings per Share
209 / 359Dividend yield
0 / 6Total Cash
189 / 358Performance 3 years
318 / 368Performance 5 years
300 / 368Performance 10 years
265 / 368Linearity 3 years
309 / 368Linearity 5 years
244 / 368Linearity 10 years
217 / 368Total Rank
238 / 368Dividend Rank
61 / 368Valuation Rank
317 / 368Piotroski Rank
221 / 368Muliplier Rank
84 / 368EBITDA - BCAB ranking 232 / 337
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.